Clinical utility of circulating tumor DNA for colorectal cancer

@inproceedings{Osumi2019ClinicalUO,
  title={Clinical utility of circulating tumor DNA for colorectal cancer},
  author={Hiroki Osumi and Eiji Shinozaki and Kensei Yamaguchi and Hitoshi Zembutsu},
  booktitle={Cancer science},
  year={2019}
}
Colorectal cancer (CRC) is currently the most common type of cancer in Japan, and its prognosis has improved because of development of diagnosis and advancement in treatments including surgery and chemotherapy. However, because of intratumor heterogeneity and clonal evolution, tumors often develop resistance to treatment. Genotyping tumor tissue in search of somatic genetic alterations for actionable information has become routine examination in clinical practice. However, the inherent… CONTINUE READING
1
Twitter Mention

Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 77 REFERENCES

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic